ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.96865
0.15%
Brent Oil
84.065
0.63%
Bitcoin
57,771.48
-0.80%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. MiMedx Group Inc (MDXG)

  7. MiMedx Group Inc (MDXG) Noticias

MDXG MiMedx Group Inc

7.31
0.00 (0.00%)
Pre Mercado
Última actualización: 03:09:34
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
MiMedx Group Inc MDXG NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 7.31 03:09:34
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
7.31
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202415:01GLOBEMIMEDX Announces First Quarter 2024 Operating and Financial..
16/4/202407:00GLOBEMIMEDX to Host First Quarter 2024 Operating and Financial..
27/3/202407:00GLOBEMIMEDX Provides Update on AXIOFILL® Request for Designation..
20/3/202406:00GLOBEMIMEDX Expands Portfolio with Fibrillar Collagen Wound..
13/3/202407:00GLOBEMIMEDX Introduces E-Commerce and Account Management Platform
05/3/202417:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202417:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202417:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202407:11EDGAR2Form 8-K - Current report
04/3/202407:00GLOBEMIMEDX Announces Appointment of Two New Independent..
28/2/202415:22EDGAR2Form 8-K - Current report
28/2/202415:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202415:01GLOBEMIMEDX Announces Fourth Quarter and Full Year 2023 Operating..
21/2/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202414:55EDGAR2Form 144 - Report of proposed sale of securities
20/2/202407:00GLOBEMIMEDX to Present at TD Cowen 44th Annual Health Care..
16/2/202415:37EDGAR2Form 144 - Report of proposed sale of securities
16/2/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202414:11EDGAR2Form 144 - Report of proposed sale of securities
14/2/202415:13EDGAR2Form 144 - Report of proposed sale of securities
12/2/202407:00GLOBEMIMEDX to Host Fourth Quarter and Full Year 2023 Operating..
22/1/202407:09EDGAR2Form 8-K - Current report
22/1/202407:00GLOBEMIMEDX Announces Improved Capital Structure with New Senior..
29/12/202316:00GLOBEMIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year..
28/12/202315:30EDGAR2Form 8-K - Current report
28/12/202307:00GLOBEMIMEDX Announces Conversion of Outstanding Series B..
27/12/202315:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202315:42EDGAR2Form SC 13D/A - General statement of acquisition of..
22/11/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202307:14EDGAR2Form 8-K - Current report
13/11/202307:00GLOBEMIMEDX to Participate in Upcoming Investor Conferences
02/11/202307:00GLOBEMIMEDX to Highlight Published Data at SAWC Fall
30/10/202315:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202315:05EDGAR2Form 8-K - Current report
30/10/202315:01GLOBEMIMEDX Announces Third Quarter 2023 Operating and Financial..
16/10/202307:00GLOBEMIMEDX to Host Third Quarter 2023 Operating and Financial..
26/9/202307:00GLOBEMIMEDX Announces Launch of EPIEFFECT™
05/9/202316:00EDGAR2Form 8-K - Current report
05/9/202307:38EDGAR2Form 8-K - Current report
05/9/202307:00GLOBEMIMEDX to Present at Upcoming Investor Conferences
01/8/202315:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202315:03EDGAR2Form 8-K - Current report
01/8/202315:01GLOBEMIMEDX Announces Second Quarter 2023 Operating and Financial..
25/7/202315:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
25/7/202315:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
18/7/202307:00GLOBEMIMEDX to Host Second Quarter 2023 Operating and Financial..
11/7/202307:30GLOBEMIMEDX Announces Favorable Ruling in Putative Securities..
06/7/202317:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202317:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/7/202308:02EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
MDXG
MiMedx
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados